Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
James M. Youakim, MD
JCP
Original Research
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study
September 23, 2015
Michael E. Thase
,
James M. Youakim
,
Aleksandar Skuban
, et al
JCP
Original Research
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
September 23, 2015
Michael E. Thase
,
James M. Youakim
,
Aleksandar Skuban
, et al
JCP
Original Research
Adjunctive Armodafinil for Schizophrenia
August 24, 2010
Read a full article on the efficacy and safety of adjunctive armodafinil therapy for cognitive deficits from schizophrenia.
John M. Kane
,
Deepak C. D' Souza
,
Ashwin A. Patkar
, et al
JCP
Original Research
Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
July 27, 2010
Joseph R. Calabrese
,
Terence A. Ketter
,
James M. Youakim
, et al